Article: CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.

Full Text (publisher's website) ; Article Metadata ; Article Data (extracted)
Asfaw A; Ali D; Eticha T; Alemayehu A; Alemayehu M; Kindeya F
PLoS ONE, 2015

10.1371/journal.pone.0122583.t002

Table 2 Results of logistic regression analysis of baseline characteristics associated with the risk of immunological non-response (an increase of <50 cells/μl).

Characteristics		Risk of immunological non-response at 12 months
		OR (95% CI)	p value
Gender	Female	1
	Male	2.02 (1.26, 3.24)	0.004
Age (years)	≤45	1
	>45	1.34 (0.81, 2.22)	0.261
WHO clinical stage	I	1
	II	1.07 (0.52, 2.17)	0.859
	III	1.21 (0.64, 2.31)	0.554
	IV	1.23 (0.47, 3.22)	0.678
Baseline CD4 count	≤200	1
	201-350	1.90 (1.14, 3.18)	0.014
	>350	5.53 (2.77, 11.04)	0.000
Weight (kg)	<40	1
	40-60	1.05 (0.50, 2.17)	0.901
	>60	1.26 (0.45, 3.55)	0.668

Report miscurated data

Inferred neuron-electrophysiology data values

Neuron Type	Neuron Description	Ephys Prop	Extracted Value	Standardized Value	Content Source